Equities analysts predict that Microbot Medical Inc. (NASDAQ:MBOT – Get Rating) will report earnings per share of ($0.42) for the current quarter, according to Zacks. Zero analysts have made estimates for Microbot Medical’s earnings. Microbot Medical posted earnings of ($0.34) per share during the same quarter last year, which suggests a negative year-over-year growth rate of 23.5%. The business is expected to issue its next earnings results on Monday, January 1st.
According to Zacks, analysts expect that Microbot Medical will report full-year earnings of ($1.85) per share for the current financial year. For the next fiscal year, analysts anticipate that the company will post earnings of ($1.53) per share. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that cover Microbot Medical.
Separately, Zacks Investment Research raised Microbot Medical from a “sell” rating to a “hold” rating in a report on Thursday.
Shares of Microbot Medical stock opened at $5.95 on Thursday. The company’s fifty day simple moving average is $5.70 and its 200-day simple moving average is $5.76. Microbot Medical has a 1 year low of $4.31 and a 1 year high of $9.60.
Microbot Medical Company Profile (Get Rating)
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio.
- Get a free copy of the StockNews.com research report on Microbot Medical (MBOT)
- MarketBeat: Week in Review 5/30 – 6/3
- Dividend Capture Strategy: What You Need to Know
- Don’t Bet On A Bounce For RH
- Xiaomi Co: Facing Macro Headwinds
- Okta On Verge Of Multi-Week Rally
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.